Zobrazeno 1 - 10
of 40
pro vyhledávání: '"E. G. Chistyakova"'
Autor:
T. V. Sleptsova, E. I. Alexeeva, K. V. Savost’yanov, A. A. Pushkov, T. M. Bzarova, S. I. Valieva, O. L. Lomakina, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova
Publikováno v:
Педиатрическая фармакология, Vol 13, Iss 2, Pp 143-148 (2016)
The article shows the observation of rare NLPC4-associated autoinflammatory syndrome with enterocolitis and familial cold urticaria. Diagnosis is confirmed molecularly-genetically: previously not described mutation c.928C>T in the heterozygous state
Externí odkaz:
https://doaj.org/article/02d2b0c5e3464d21b2c28ffab04d2102
Autor:
T. V. Sleptsova, E. I. Alekseeva, K. V. Savostianov, A. A. Pushkov, T. M. Bazarova, S. I. Valieva, O. L. Lomakina, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova
Publikováno v:
Педиатрическая фармакология, Vol 12, Iss 4, Pp 456-561 (2015)
The article presents the monitoring of a severe course of CINCA/NOMID syndrome diagnosed at late stages. The use of monoclonal antibodies to IL 1 — kanakinumabum — in a patient with chronic neurological cutaneous and articular syndrome was succes
Externí odkaz:
https://doaj.org/article/9ae97665029648699710b33facbddec0
Autor:
E. I. Alexeeva, T. M. Bzarova, S. I. Valieva, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, T. V. Sleptsova, N. I. Taibulatov, A. N. Fetisova, M. Sh. Shingarova
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 4, Pp 464-476 (2015)
Background: Treatment of patients with juvenile idiopathic arthritis (JIA) is one of the most complex and urgent problems of rheumatology.Objective: Our aim was to evaluate the efficacy and safety of adalimumab therapy combined with immunosuppressant
Externí odkaz:
https://doaj.org/article/69be06a3af994846b8c5ae690962d944
Autor:
T. M. Bzarova, E. I. Alexeeva, S. I. Valieva, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, T. V. Sleptsova, A. N. Fetisova, N. I. Taibulatov
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 4, Pp 489-496 (2015)
Background: An issue related to the terms of assignment of genetically engineered biological agents to patients with juvenile idiopathic arthritis (JIA) still remains debatable in pediatric rheumatology.Objective: Our aim was to evaluate the efficacy
Externí odkaz:
https://doaj.org/article/a820173d736749ee9b2272057a066d77
Autor:
A. A. Baranov, E. I. Alexeeva, T. M. Bzarova, S. I. Valieva, K. B. Isaeva, E. G. Chistyakova, A. M. Chomakhidze, R. V. Denisova, T. V. Sleptsova, A. N. Fetisova, O. L. Lomakina
Publikováno v:
Вопросы современной педиатрии, Vol 14, Iss 2, Pp 224-235 (2015)
Treatment of juvenile idiopathic arthritis (JIA) is one of the most complex and urgent problems of rheumatology. Objective: We undertook a study to evaluate the effectiveness and safety of long-term therapy with etanercept in patients with JIA withou
Externí odkaz:
https://doaj.org/article/b24614b13bea42e49b3806b11d2c0dc4
Autor:
A. N. Fetisova, E. I. Alexeeva, T. M. Bzarova, S. I. Valieva, V. V. Chernikov, I. V. Vinyarskaya, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova, Т. V. Sleptsova, N. I. Taibulatov
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 4, Pp 26-32 (2014)
Aim: To assess the influence of the genetically engineered biologic drug etanercept on the quality of life of patients with juvenile idiopathic arthritis (JIA). Patients and methods: The research included 85 children with poly-and oligoarticular vari
Externí odkaz:
https://doaj.org/article/f481b948196f469fb675d8ee86d3a6bb
Autor:
K. B. Isaeva, E. I. Alexeeva, R. V. Denisova, T. V. Sleptsova, Т. М. Bzarova, S. I. Valieva, E. V. Mitenko, E. G. Chistyakova, А. М. Chomakhidze
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 4, Pp 156-161 (2014)
The case of early debut and heavy course of juvenile idiopathic arthritis in the patient at the age of 1 year and 8 months, associated with uveitis refractory to the therapy by methotrexate and nonsteroid antiinflammatory preparations is presented. T
Externí odkaz:
https://doaj.org/article/0c94d7663ca6468cb8ac9e38e5faf23a
Autor:
T. V. Sleptsova, E. I. Alexeeva, T. M. Bzarova, R. V. Denisova, K. B Isaeva, E. G. Chistyakova, A. N. Fetisova, O. L. Lomakina
Publikováno v:
Педиатрическая фармакология, Vol 11, Iss 4, Pp 97-102 (2014)
The article presents a case of late diagnosis of cutaneomucosal lymphonodular syndrome (Kawasaki syndrome). The child featured fever, mucosal lesion (conjunctivitis, stomatitis), rash, thick edemas on arms and feet, arthritis and coronaritis. Initial
Externí odkaz:
https://doaj.org/article/847c814d2caf4371bb95f8fe4a1da039
Autor:
T. V. Sleptsova, E. I. Alexeeva, K. V. Savost’yanov, A. A. Pushkov, A. G. Nikitin, T. M. Bzarova, S. I. Valieva, A. N. Fetisova, A. V. Pakhomov, N. V. Zhurkova, R. V. Denisova, K. B. Isaeva, E. G. Chistyakova
Publikováno v:
Вопросы современной педиатрии, Vol 13, Iss 3, Pp 97-103 (2014)
The article describes the monitoring of severe cryopyrin-associated syndrome (syndrome CINCA/NOMID). The following clinical case indicates successful application of homogeneous antibodies to interleukin 1 — canakinumab — in patient with chronic n
Externí odkaz:
https://doaj.org/article/c4e2f6cb60724f079bcaac6c72e71609
Autor:
E. I. Alexeeva, R. V. Denisova, T. V. Sleptsova, T. M. Bzarova, K. B. Isaeva, E. V. Mitenko, E. G. Chistyakova, A. M. Chomakhidze, N. I. Taybulatov, A. N. Fetisova, O. L. Lomakina, S. I. Valieva
Publikováno v:
Педиатрическая фармакология, Vol 11, Iss 2, Pp 88-94 (2014)
The article presents a case of successful use of an interleukin-1 monoclonal antibody drug (canakinumab) for severe systemic juvenile idiopathic arthritis refractory to treatment with classic immunosuppressants and genetically engineered biopharmaceu
Externí odkaz:
https://doaj.org/article/74f2cdba75ec4660a374045f500a0598